What is GRDX revenue?

GridAI Technologies Corp. (GRDX) reported $36.3K of revenue for fiscal 2025 (ended Dec 31, 2025).

No. GridAI Technologies Corp. reported a net loss of $6.39M for fiscal 2025 (ended Dec 31, 2025).

How much cash and debt does GRDX have?

GridAI Technologies Corp. reported $1.38M in cash and cash equivalents and $1.68M of debt on its most recent balance sheet in SEC filings.

Where does GRDX stock trade?

GridAI Technologies Corp. (GRDX) is listed on NASDAQ.

What sector and industry is GRDX in?

GridAI Technologies Corp. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.

When did GridAI Technologies Corp. go public?

GridAI Technologies Corp. (GRDX) completed its IPO in 2016.

What companies are similar to GRDX?

Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare GRDX side-by-side with any of them on Quantisnow.

How can I track GRDX on Quantisnow?

Quantisnow aggregates GridAI Technologies Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GRDX to receive live email and push alerts on every new disclosure.

GRDX

NASDAQ

GridAI Technologies Corp.

SectorHealth Care IndustryBiotechnology: Pharmaceutical PreparationsIPO2016

Follow + get alerts

GridAI Technologies Corp. (GRDX) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 16 wire items for GRDX, including 8 SEC filings, 7 insider trades and 1 press release or news item. The most recent was published Oct 30, 2026.

GRDX rankings

Financial highlights

Full financials

Revenue, FY2025: $36.3K
Net income, FY2025: -$6.39M
Net margin: -17634.4%
Cash: $1.38M

For fiscal 2025 (ended Dec 31, 2025), from SEC filings. Not investment advice.

News · 26 weeks33+367%

2026-05-102026-11-01

Mix2090d

SEC Filings12(60%)
Insider7(35%)
Other1(5%)

Latest news

25 items

GRDX FAQ

9 questions

What is the latest news on GRDX?
In the last 30 days Quantisnow tracked 16 wire items for GRDX: 8 SEC filings, 7 insider trades and 1 press release or news item. The most recent was published on October 30, 2026.
What is GRDX revenue?
GridAI Technologies Corp. (GRDX) reported $36.3K of revenue for fiscal 2025 (ended Dec 31, 2025).
Is GRDX profitable?
No. GridAI Technologies Corp. reported a net loss of $6.39M for fiscal 2025 (ended Dec 31, 2025).
How much cash and debt does GRDX have?
GridAI Technologies Corp. reported $1.38M in cash and cash equivalents and $1.68M of debt on its most recent balance sheet in SEC filings.
Where does GRDX stock trade?
GridAI Technologies Corp. (GRDX) is listed on NASDAQ.
What sector and industry is GRDX in?
GridAI Technologies Corp. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
When did GridAI Technologies Corp. go public?
GridAI Technologies Corp. (GRDX) completed its IPO in 2016.
What companies are similar to GRDX?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare GRDX side-by-side with any of them on Quantisnow.
How can I track GRDX on Quantisnow?
Quantisnow aggregates GridAI Technologies Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GRDX to receive live email and push alerts on every new disclosure.